Not true.You would be at the HIV conference in Miami....where the experts in HIV will be scrutinizing the data and the method.
But MM has put her name to this paper and announced it to the HIV scientific community for scrutiny.
The data has been analysed by an independant HIV expert.
BIT has not been upramped by traders at all.
You don't understand how the market works.
btw. You do part value a biotech breakthrough such a this by the potential earnings of the anti-HIV drug sector.
That is precisely one of the ways to determine a value and is used. Realistic Potential based on past sales.
If BIT225 works, It really is quite simple.
Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data, page-560
-
- There are more pages in this discussion • 479 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
-0.001(4.76%) |
Mkt cap ! $18.04M | |||
| Open | High | Low | Value | Volume |
| 2.1¢ | 2.1¢ | 2.0¢ | $12.00K | 600.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 972631 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 199783 | 1 |
View Market Depth
| Last trade - 14.33pm 01/11/2024 (20 minute delay) ? |
| BIT (ASX) Chart |